Uncategorized
U.K. Ophthalmologists Lead in Treatment of Wet AMD Patients with Oraya Therapy Across Europe
NEWARK, Calif. & LIVERPOOL, England--(BUSINESS WIRE)--Oraya Therapeutics Inc. announced today at the Royal College of Ophthalmologists Annual Congress that U.K. ophthalmologists are the leading adopters of Oraya Therapy for the treatment of wet age-related macular degeneration (AMD), two years after the treatment was introduced in the country. Sheffield Teaching Hospitals NHS Foundation Trust alone has treated more than 150 patients in the year since the service was commissioned, with other Nat
